“Regional Impact of Prophylaxis With the Monoclonal Antibody Palivizumab on Ospitalizations from Respiratory Syncytial Virus in Infants”. Swiss Medical Weekly, vol. 131, no. 1112, Mar. 2001, pp. 146-51, https://doi.org/10.4414/smw.2001.09681.